Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia

NCT04319900 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Novel Coronavirus Pnuemonia

Interventions

DRUG: favipiravir tablets+chloroquine phosphatetablets tablets
DRUG: Favipiravir tablets
DRUG: Placebo

Sponsor

Beijing Chao Yang Hospital